| Accession | Acc. Gene-, Name | Start | End | Subsequence | Logic | PDB | Organism | Length |
|---|---|---|---|---|---|---|---|---|
| ELMI003898 | P42224 STAT1 STAT1_HUMAN |
22 | 26 | LEQVHQLYDDSFPMEIRQYL | FP | --- | Homo sapiens (Human) | 750 |
Instance evidence
| Evidence class | PSI-MI | Method | BioSource | PubMed | Logic | Reliability | Notes |
|---|---|---|---|---|---|---|---|
| experimental | MI:0053 | fluorescence polarization spectroscopy | in vitro | Kaneko,2010 | not specified | unlikely | InteractionDetection |
Interactions
| Uniprot Id | Domain family | Domain Start | Domain End | Affinity Min/Max (µMol) | Notes |
|---|---|---|---|---|---|
| (Q9ULZ2) STAP1_HUMAN | PF00017
(SH2)
SH2 domain |
179 | 256 | 1.37/1.47 | [mitab][xml] |
Pathways
- AGE RAGE signaling pathway in diabetic complications
- C type lectin receptor signaling pathway
- Chemokine signaling pathway
- Coronavirus disease COVID 19
- Epstein Barr virus infection
- Growth hormone synthesis, secretion and action
- Hepatitis B
- Hepatitis C
- Herpes simplex virus 1 infection
- Human papillomavirus infection
- Inflammatory bowel disease
- Influenza A
- JAK STAT signaling pathway
- Kaposi sarcoma associated herpesvirus infection
- Leishmaniasis
- Measles
- NOD like receptor signaling pathway
- Necroptosis
- Osteoclast differentiation
- PD L1 expression and PD 1 checkpoint pathway in cancer
- Pancreatic cancer
- Pathways in cancer
- Prolactin signaling pathway
- Th1 and Th2 cell differentiation
- Th17 cell differentiation
- Thyroid hormone signaling pathway
- Toll like receptor signaling pathway
- Toxoplasmosis
- Tuberculosis
Please cite:
The Eukaryotic Linear Motif resource: 2022 release.
(PMID:34718738)
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement